Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - EDBOOK
LB  - 1.
AU  - Aitkenhead, AR
AU  - Smith, G
AU  - Rowbotham, DJ
TI  - Textbook of anaesthesia
ET  - 5th
CY  - Edinburgh
PB  - Churchill Livingstone, Elsevier
PY  - 2007
ER  - 
TY  - BOOK
LB  - 2.
AU  - Steele, SM
AU  - Nielsen, KC
AU  - Klein, SM
TI  - Ambulatory anesthesia and perioperative analgesia
CY  - New York
PB  - McGraw-Hill Professional
PY  - 2005
ER  - 
TY  - CHAP
LB  - 3.
AU  - Fink, H
AU  - Blobner, M
AU  - Martyn, JA
TI  - Neuromuscular blocking agents and reversal drugs
A2  - Evers, A
A2  - Maze, M
T2  - Anesthetic pharmacology: physiologic principles and clinical practice
CY  - Philadelphia, PA
PB  - Churchill Livingstone
PY  - 2004
SP  - 573
EP  - 597
ER  - 
TY  - JOUR
LB  - 4.
AU  - Combs, JM
AU  - Combs, GN
TI  - A literature review of the newest muscle relaxant: ORG 9426
J2  - CRNA
PY  - 1994
VL  - 5
SP  - 104
EP  - 112
ER  - 
TY  - JOUR
LB  - 5.
AU  - Dell, DD
AU  - Kehoe, C
TI  - Plasma cholinesterase deficiency
J2  - J Perianesth Nurs
PY  - 1996
VL  - 11
SP  - 304
EP  - 308
ER  - 
TY  - JOUR
LB  - 6.
AU  - Beaussier, M
AU  - Boughaba, MA
TI  - Residual neuromuscular blockade
J2  - Ann Fr Anesth Reanim
PY  - 2005
VL  - 24
SP  - 1266
EP  - 1274
ER  - 
TY  - JOUR
LB  - 7.
AU  - Bevan, DR
AU  - Donati, F
AU  - Kopman, AF
TI  - Reversal of neuromuscular blockade
J2  - Anesthesiology
PY  - 1992
VL  - 77
SP  - 785
EP  - 805
ER  - 
TY  - JOUR
LB  - 8.
AU  - Fuchs-Buder, T
AU  - Claudius, C
AU  - Skovgaard, LT
AU  - Eriksson, LI
AU  - Mirakhur, RK
AU  - Viby-Mogensen, J
TI  - Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision
J2  - Acta Anaesthesiol Scand
PY  - 2007
VL  - 51
SP  - 789
EP  - 808
ER  - 
TY  - GEN
LB  - 9.
AU  - National Horizon Scanning Centre
TI  - Sugammadex (Org 25969) for reversal of muscle relaxation in general anaesthesia: horizon scanning technology briefing
CY  - Birmingham
PB  - National Horizon Scanning Centre (NHSC)
PY  - 2006
ER  - 
TY  - RPRT
LB  - 10.
AU  - European Medicines Agency (EMEA)
TI  - Assessment report for bridion. International nonproprietary name: sugammadex. Procedure no. EMEA/H/C/000885
CY  - London
PB  - EMEA
PY  - 2008
ER  - 
TY  - GEN
LB  - 11.
AU  - Esmeron
TI  - Medicines compendium
ET  - 10th
CY  - Leatherhead
PB  - Datapharm Communications Ltd
PY  - 2008
SP  - 926
EP  - 928
UR  - http://emc.medicines.org.uk/document.aspx?documentId = 5166
ER  - 
TY  - GEN
LB  - 12.
AU  - Food and Drug Administration (FDA), Center for Drug Evaluation and Research, Division of Anesthesia Analgesia and Rheumatology Products
TI  - Briefing document for the Anesthesia and Life Support Drug Advisory Committee meeting. March 11, 2008. Bridion. NDA 22–225
CY  - Silver Spring, MD
PB  - Department of Health & Human Services, FDA, Center for Drug Evaluation & Research, Division of Anesthesia, Analgesia and Rheumatology Products
PY  - 2008
ER  - 
TY  - JOUR
LB  - 13.
AU  - Hemmerling, TM
AU  - Le, N
TI  - Brief review: neuromuscular monitoring: an update for the clinician
J2  - Can J Anaesth
PY  - 2007
VL  - 54
SP  - 58
EP  - 72
ER  - 
TY  - JOUR
LB  - 14.
AU  - Kopman, AF
AU  - Zhaku, B
AU  - Lai, KS
TI  - The ‘intubating dose’ of succinylcholine: the effect of decreasing doses on recovery time
J2  - Anesthesiology
PY  - 2003
VL  - 99
SP  - 1050
EP  - 1054
ER  - 
TY  - JOUR
LB  - 15.
AU  - Naguib, M
TI  - Sugammadex: another milestone in clinical neuromuscular pharmacology
J2  - Anesth Analg
PY  - 2007
VL  - 104
SP  - 575
EP  - 581
ER  - 
TY  - JOUR
LB  - 16.
AU  - Sorgenfrei, IF
AU  - Norrild, K
AU  - Larsen, PB
AU  - Stensballe, J
AU  - Ostergaard, D
AU  - Prins, ME
TI  - Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study
J2  - Anesthesiology
PY  - 2006
VL  - 104
SP  - 667
EP  - 674
ER  - 
TY  - JOUR
LB  - 17.
AU  - Nicholson, WT
AU  - Sprung, J
AU  - Jankowski, CJ
TI  - Sugammadex: a novel agent for the reversal of neuromuscular blockade
J2  - Pharmacotherapy
PY  - 2007
VL  - 27
SP  - 1181
EP  - 1188
ER  - 
TY  - JOUR
LB  - 18.
AU  - Welliver, M
AU  - McDonough, J
AU  - Kalynych, N
AU  - Redfern, R
TI  - Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent
J2  - Drug Design Dev Ther
PY  - 2008
VL  - 2
SP  - 49
EP  - 59
ER  - 
TY  - JOUR
LB  - 19.
AU  - Lu, G
AU  - Ades, AE
TI  - Combination of direct and indirect evidence in mixed treatment comparisons
J2  - Stat Med
PY  - 2004
VL  - 23
SP  - 3105
EP  - 3124
ER  - 
TY  - JOUR
LB  - 20.
AU  - Higgins, JP
AU  - White, IR
AU  - Anzures-Cabrera, J
TI  - Meta-analysis of skewed data: combining results reported on log-transformed or raw scales
J2  - Stat Med
PY  - 2008
VL  - 27
SP  - 6072
EP  - 6092
ER  - 
TY  - JOUR
LB  - 21.
AU  - Ali, HH
AU  - Utting, JE
AU  - Gray, TC
TI  - Quantitative assessment of residual antidepolarizing block. II
J2  - Br J Anaesth
PY  - 1971
VL  - 43
SP  - 478
EP  - 485
ER  - 
TY  - JOUR
LB  - 22.
AU  - Ali, HH
AU  - Utting, JE
AU  - Gray, TC
TI  - Quantitative assessment of residual antidepolarizing block. I
J2  - Br J Anaesth
PY  - 1971
VL  - 43
SP  - 473
EP  - 477
ER  - 
TY  - GEN
LB  - 23.
AU  - Organon, Schering-Plough
TI  - FDA Anesthetic and Life Support Advisory Committee meeting. Sugammadex sodium injection (NDA 22–225). March 11, 2008. Briefing document (background package)
CY  - Kenilworth, NJ: Organon USA
PB  - Schering-Plough Corporation
PY  - 2008
ER  - 
TY  - GEN
LB  - 24.
AU  - Centre for Reviews and Dissemination (CRD)
TI  - Systematic reviews: CRD’s guidance for undertaking reviews in health care
CY  - York
PB  - University of York
PY  - 2009
ER  - 
TY  - JOUR
LB  - 25.
AU  - Caldwell, DM
AU  - Ades, AE
AU  - Higgins, JPT
TI  - Simultaneous comparison of multiple treatments: combining direct and indirect evidence
J2  - BMJ
PY  - 2005
VL  - 331
SP  - 897
EP  - 900
ER  - 
TY  - GEN
LB  - 26.
AU  - Organon
TI  - Comparison of sugammadex with neostigmine during laparoscopic cholecystectomy or appendectomy (Study 19.4.318AM2)
CY  - Bethesda, MD
PB  - National Library of Medicine (US)
PY  - 2008
Y2  - 11 September 2008
UR  - http://clinicaltrials.gov/show/NCT00724932 NLM Identifier: NCT00724932
ER  - 
TY  - GEN
LB  - 27.
AU  - Organon
TI  - Comparison of 4.0 mg/kg sugammadex at 1–2 PTC in renal or control patients (19.4.328)
CY  - Bethesda, MD
PB  - National Library of Medicine (US)
PY  - 2008
Y2  - 11 September 2008
UR  - http://clinicaltrials.gov/show/NCT00702715 NLM Identifier: NCT00702715
ER  - 
TY  - GEN
LB  - 28.
AU  - Organon
TI  - Comparison sugammadex administered at 1–2 PTCs or better with neostigmine administered as per standard of care to reverse rocuronium-induced neuromuscular blockade in adult subjects undergoing elective open abdominal procedure (19.4.334)
CY  - Bethesda, MD
PB  - National Library of Medicine (US)
PY  - 2008
Y2  - 11 September 2008
UR  - http://clinicaltrials.gov/show/NCT00675792 NLM Identifier: NCT00675792
ER  - 
TY  - JOUR
LB  - 29.
AU  - Flockton, EA
AU  - Mastronardi, P
AU  - Hunter, JM
AU  - Gomar, C
AU  - Mirakhur, RK
AU  - Aguilera, L
TI  - Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine
J2  - Br J Anaesth
PY  - 2008
VL  - 100
SP  - 622
EP  - 630
ER  - 
TY  - JOUR
LB  - 30.
AU  - Blobner, M
AU  - Eriksson, L
AU  - Scholz, J
AU  - Hillebrand, H
AU  - Pompei, L
TI  - Sugammadex (2.0 mg/kg) significantly faster reverses shallow rocuronium-induced neuromuscular blockade compared with neostigmine (50 mcg/kg) [abstract]
J2  - Eur J Anaesthesiol
PY  - 2007
VL  - 24
SP  - 125
ER  - 
TY  - GEN
LB  - 31.
AU  - Organon
TI  - A bridging trial comparing Org 25969 at reappearance of T2 in Japanese and Caucasian subjects. Part A: Japanese subjects (19.4.208A)
CY  - Bethesda, MD
PB  - National Library of Medicine (US)
PY  - 2006
Y2  - 11 September 2008
UR  - http://clinicaltrials.gov/show/NCT00591409 NLM Identifier: NCT00591409
ER  - 
TY  - JOUR
LB  - 32.
AU  - Sparr, HJ
AU  - Vermeyen, KM
AU  - Beaufort, AM
AU  - Rietbergen, H
AU  - Proost, JH
AU  - Saldien, V
TI  - Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics
J2  - Anesthesiology
PY  - 2007
VL  - 106
SP  - 935
EP  - 943
ER  - 
TY  - JOUR
LB  - 33.
AU  - Groudine, SB
AU  - Soto, R
AU  - Lien, C
AU  - Drover, D
AU  - Roberts, K
TI  - A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block
J2  - Anesth Analg
PY  - 2007
VL  - 104
SP  - 555
EP  - 562
ER  - 
TY  - JOUR
LB  - 34.
AU  - Puhringer, FK
AU  - Rex, C
AU  - Sielenkamper, AW
AU  - Claudius, C
AU  - Larsen, PB
AU  - Prins, ME
TI  - Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial
J2  - Anesthesiology
PY  - 2008
VL  - 109
SP  - 188
EP  - 197
ER  - 
TY  - JOUR
LB  - 35.
AU  - Duvaldestin, P
AU  - Kuizenga, K
AU  - Kjaer, CC
AU  - Saldien, V
AU  - Debaene, B
TI  - Sugammadex achieves fast recovery from profound neuromuscular blockade induced by rocuronium or vecuronium: a dose–response study [abstract]
J2  - Eur J Anaesthesiol
PY  - 2007
VL  - 24
SP  - 123
ER  - 

LB  - 36.
AU  - Jones, RK
AU  - Caldwell, JE
AU  - Brull, SJ
AU  - Soto, R
TI  - Faster reversal of profound rocuronium-induced neuromuscular blockade with sugammadex vs neostigmine [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 13–17 October 2007
CY  - San Francisco, CA
PY  - 2007
SP  - A1577
ER  - 

LB  - 37.
AU  - Lemmens, HJM
AU  - El-Orbany, MI
AU  - Berry, J
AU  - Martin, G
TI  - Sugammadex reverses profound vecuronium blockade more rapidly than neostigmine [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 13–17 October 2007
CY  - San Francisco, CA
PY  - 2007
SP  - A1578
ER  - 
TY  - JOUR
LB  - 38.
AU  - Jones, RK
AU  - Caldwell, JE
AU  - Brull, SJ
AU  - Soto, RG
TI  - Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine
J2  - Anesthesiology
PY  - 2008
VL  - 109
SP  - 816
EP  - 824
ER  - 
TY  - GEN
LB  - 39.
AU  - Organon
TI  - A bridging trial comparing Org 25969 at 1–2 PTC in Japanese and Caucasian subjects. Part A: Japanese subjects (19.4.209A)
CY  - Bethesda, MD
PB  - National Library of Medicine (US)
PY  - 2005–2006
Y2  - 30 May 2008
UR  - http://clinicaltrials.gov/show/NCT00591786 NLM Identifier: NCT00591786
ER  - 
TY  - JOUR
LB  - 40.
AU  - de Boer, HD
AU  - Driessen, JJ
AU  - Marcus, MAE
AU  - Kerkkamp, H
AU  - Heeringa, M
AU  - Klimek, M
TI  - Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study
J2  - Anesthesiology
PY  - 2007
VL  - 107
SP  - 239
EP  - 244
ER  - 

LB  - 41.
AU  - Lee, C
AU  - Jahr, JS
AU  - Candiotti, K
AU  - Warriner, B
AU  - Zornow, MH
TI  - Reversal of profound rocuronium NMB with sugammadex is faster than recovery from succinylcholine [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 13–17 October 2007
CY  - San Francisco, CA
PY  - 2007
SP  - A988
ER  - 
TY  - JOUR
LB  - 42.
AU  - Adamus, M
AU  - Belohlavek, R
AU  - Koutna, J
AU  - Vujcikova, M
AU  - Janaskova, E
TI  - Cisatracurium vs. rocuronium: a prospective, comparative, randomized study in adult patients under total intravenous anaesthesia
J2  - Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
PY  - 2006
VL  - 150
SP  - 333
EP  - 338
ER  - 
TY  - JOUR
LB  - 43.
AU  - Bailey, DM
AU  - Nicholas, AD
TI  - Comparison of atracurium and vecuronium during anaesthesia for laparoscopy
J2  - Br J Anaesth
PY  - 1988
VL  - 61
SP  - 557
EP  - 559
ER  - 
TY  - JOUR
LB  - 44.
AU  - Barrio, J
AU  - San Miguel, G
AU  - Garcia, V
AU  - Pelegrin, F
TI  - Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial
J2  - Rev Esp Anestesiol Reanim
PY  - 2007
VL  - 54
SP  - 399
EP  - 404
ER  - 
TY  - JOUR
LB  - 45.
AU  - Berg, H
AU  - Roed, J
AU  - Viby-Mogensen, J
AU  - Mortensen, CR
AU  - Engbaek, J
AU  - Skovgaard, LT
TI  - Residual neuromuscular block is a risk factor for postoperative pulmonary complications: a prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium
J2  - Acta Anaesthesiol Scand
PY  - 1997
VL  - 41
SP  - 1095
EP  - 1103
ER  - 
TY  - JOUR
LB  - 46.
AU  - Bevan, JC
AU  - Collins, L
AU  - Fowler, C
AU  - Kahwaji, R
AU  - Rosen, HD
AU  - Smith, MF
TI  - Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children
J2  - Anesth Analg
PY  - 1999
VL  - 89
SP  - 333
EP  - 339
ER  - 
TY  - JOUR
LB  - 47.
AU  - Carroll, MT
AU  - Mirakhur, RK
AU  - Lowry, D
AU  - Glover, P
AU  - Kerr, CJ
TI  - A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium
J2  - Anaesthesia
PY  - 1998
VL  - 53
SP  - 744
EP  - 748
ER  - 
TY  - JOUR
LB  - 48.
AU  - Della Rocca, G
AU  - Pompei, L
AU  - Coccia, C
AU  - Costa, MG
AU  - Cecchini, V
AU  - Vilardi, V
TI  - Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure
J2  - Minerva Anestesiol
PY  - 2003
VL  - 69
SP  - 605
EP  - 615
ER  - 
TY  - JOUR
LB  - 49.
AU  - Suy, K
AU  - Morias, K
AU  - Cammu, G
AU  - Hans, P
AU  - van Duijnhoven, WGF
AU  - Heeringa, M
TI  - Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent
J2  - Anesthesiology
PY  - 2007
VL  - 106
SP  - 283
EP  - 288
ER  - 
TY  - JOUR
LB  - 50.
AU  - Puhringer, F
AU  - Blaszyk, M
AU  - Cammu, G
AU  - Sparr, H
AU  - Heeringa, M
TI  - Sugammadex achieves fast recovery from shallow neuromuscular blockade induced by rocuronium or vecuronium: dose-response studies [abstract]
J2  - Eur J Anaesthesiol
PY  - 2007
VL  - 24
SP  - 111
ER  - 
TY  - JOUR
LB  - 51.
AU  - Staals, LM
AU  - Snoeck, MM
AU  - Driessen, JJ
AU  - Flockton, EA
AU  - Heeringa, M
AU  - Hunter, JM
TI  - Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function
J2  - Br J Anaesth
PY  - 2008
VL  - 101
SP  - 492
EP  - 497
ER  - 
TY  - JOUR
LB  - 52.
AU  - Plaud, B
AU  - Meretoja, O
AU  - Pohl, B
AU  - Mirakhur, RK
AU  - Raft, J
TI  - Reversal of rocuronium-induced neuromuscular blockade with sugammadex in paediatric and adult patients [abstract]
J2  - Eur J Anaesthesiol
PY  - 2007
VL  - 24
SP  - 124
ER  - 

LB  - 53.
AU  - Amao, R
AU  - Zornow, MH
AU  - McTaggart Cowan, R
AU  - Cheng, DCH
AU  - Allard, M
TI  - Sugammadex safely reverses rocuronium-induced blockade in patients with pulmonary disease [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 13–17 October 2007
CY  - San Francisco, CA
PY  - 2007
SP  - A1582
ER  - 

LB  - 54.
AU  - Dahl, V
AU  - Pendeville, PE
AU  - Hollman, MW
AU  - Hier, T
AU  - Blobner, M
TI  - Reversal of rocuronium-induced neuromuscular blockade by sugammadex in cardiac patients [abstract]
T2  - American Society of Anesthesiologists. Annual meeting;
DA  - 13–17 October 2007
CY  - San Francisco, CA
PY  - 2007
SP  - A1581
ER  - 

LB  - 55.
AU  - McDonagh, DL
AU  - Benedict, PE
AU  - Kovac, AL
AU  - Drover, D
AU  - Brister, NW
TI  - Efficacy and safety of sugammadex for reversal of rocuronium-induced blockade in elderly patients [abstract]
CY  - American Society of Anesthesiologists. Annual meeting
DA  - 13–17 October 2007
CY  - San Francisco, CA
PY  - 2007
SP  - A1583
ER  - 
TY  - JOUR
LB  - 56.
AU  - Alvarez-Gomez, JA
AU  - Wattwil, M
AU  - Vanacker, B
AU  - Lora-Tamayo, JI
AU  - Khuenl-Brady, KS
TI  - Reversal of vecuronium-induced shallow neuromuscular blockade is significantly faster with sugammadex compared with neostigmine [abstract]
J2  - Eur J Anaesthesiol
PY  - 2007
VL  - 24
SP  - 124
EP  - 125
ER  - 
TY  - JOUR
LB  - 57.
AU  - Schultz, P
AU  - Ibsen, M
AU  - Ostergaard, D
AU  - Skovgaard, LT
TI  - Onset and duration of rocuronium – from tracheal intubation, through intense block to complete recovery
J2  - Acta Anaesthesiol Scand
PY  - 2001
VL  - 45
SP  - 612
EP  - 617
ER  - 
TY  - JOUR
LB  - 58.
AU  - Lee, C
AU  - Jahr, JS
AU  - Candiotti, KA
AU  - Warriner, B
AU  - Zornow, MH
AU  - Naguib, M
TI  - Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine
J2  - Anesthesiology
PY  - 2009
VL  - 110
SP  - 1020
EP  - 1025
ER  - 
TY  - JOUR
LB  - 59.
AU  - Staals, LM
AU  - Snoek, MMJ
AU  - Flockton, E
AU  - Heeringa, M
AU  - Driessen, JJ
TI  - The efficacy of sugammadex in subjects with impaired renal function [abstract]
J2  - Eur J Anaesthesiol
PY  - 2007
VL  - 24
SP  - 122
EP  - 123
ER  - 
TY  - CHAP
LB  - 60.
AU  - Marti Masso, JF
AU  - Liceaga Cundin, G
TI  - Drugs affecting autonomic functions or the extrapyramidal system. Agents with cholinergic effects
A2  - Dukes, MNG
A2  - Aronson, JK
T2  - Meyler’s side effects of drugs: an encyclopedia of adverse reactions and interactions
ET  - 14th
CY  - Amsterdam: Elsevier
PY  - 2000
SP  - 434
EP  - 440
ER  - 
TY  - ELEC
LB  - 61.
AU  - Schering-Plough Corporation
TI  - U.S. FDA issues action letter for sugammadex
UR  - www.schering-plough.com/news/news_article.aspx?reqid = 1182475
ER  - 
TY  - JOUR
LB  - 62.
AU  - Light, KP
AU  - Lovell, AT
AU  - Butt, H
AU  - Fauvel, NJ
AU  - Holdcroft, A
TI  - Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?
J2  - Pharmacoepidemiol Drug Saf
PY  - 2006
VL  - 15
SP  - 151
EP  - 160
ER  - 
TY  - JOUR
LB  - 63.
AU  - Baillard, C
AU  - Gehan, G
AU  - Reboul-Marty, J
AU  - Larmignat, P
AU  - Samama, CM
AU  - Cupa, M
TI  - Residual curarization in the recovery room after vecuronium
J2  - Br J Anaesth
PY  - 2000
VL  - 84
SP  - 394
EP  - 395
ER  - 
TY  - JOUR
LB  - 64.
AU  - Bhananker, SM
AU  - O’Donnell, JT
AU  - Salemi, JR
AU  - Bishop, MJ
TI  - The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events
J2  - Anesth Analg
PY  - 2005
VL  - 101
SP  - 819
EP  - 822
ER  - 
TY  - JOUR
LB  - 65.
AU  - Cammu, G
AU  - De Witte, J
AU  - De Veylder, J
AU  - Byttebier, G
AU  - Vandeput, D
AU  - Foubert, L
TI  - Postoperative residual paralysis in outpatients versus inpatients
J2  - Anesth Analg
PY  - 2006
VL  - 102
SP  - 426
EP  - 429
ER  - 
TY  - JOUR
LB  - 66.
AU  - Laake, JH
AU  - Rottingen, JA
TI  - Rocuronium and anaphylaxis: a statistical challenge
J2  - Acta Anaesthesiol Scand
PY  - 2001
VL  - 45
SP  - 1196
EP  - 1203
ER  - 
TY  - JOUR
LB  - 67.
AU  - Laxenaire, MC
AU  - Mertes, PM
AU  - Groupe d’Etudes des Réactions Anaphylactoides P
TI  - Anaphylaxis during anaesthesia. Results of a two-year survey in France
J2  - Br J Anaesth
PY  - 2001
VL  - 87
SP  - 549
EP  - 558
ER  - 
TY  - JOUR
LB  - 68.
AU  - Malinovsky, JM
AU  - Decagny, S
AU  - Wessel, F
AU  - Guilloux, L
AU  - Mertes, PM
TI  - Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients
J2  - Acta Anaesthesiol Scand
PY  - 2008
VL  - 52
SP  - 175
EP  - 181
ER  - 
TY  - JOUR
LB  - 69.
AU  - Maybauer, DM
AU  - Geldner, G
AU  - Blobner, M
AU  - Puhringer, F
AU  - Hofmockel, R
AU  - Rex, C
TI  - Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium
J2  - Anaesthesia
PY  - 2007
VL  - 62
SP  - 12
EP  - 17
ER  - 
TY  - JOUR
LB  - 70.
AU  - Mertes, PM
AU  - Laxenaire, M-C
AU  - Alla, F
AU  - Groupe d’Etudes des Réactions Anaphylactoides Peranesthesiques
TI  - Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000
J2  - Anesthesiology
PY  - 2003
VL  - 99
SP  - 536
EP  - 545
ER  - 
TY  - JOUR
LB  - 71.
AU  - Murphy, GS
AU  - Szokol, JW
AU  - Franklin, M
AU  - Marymont, JH
AU  - Avram, MJ
AU  - Vender, JS
TI  - Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium
J2  - Anesth Analg
PY  - 2004
VL  - 98
SP  - 193
EP  - 200
ER  - 
TY  - JOUR
LB  - 72.
AU  - Murphy, GS
AU  - Szokol, JW
AU  - Marymont, JH
AU  - Greenberg, SB
AU  - Avram, MJ
AU  - Vender, JS
TI  - Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit
J2  - Anesth Analg
PY  - 2008
VL  - 107
SP  - 130
EP  - 137
ER  - 
TY  - JOUR
LB  - 73.
AU  - Neal, SM
AU  - Manthri, PR
AU  - Gadiyar, V
AU  - Wildsmith, JA
TI  - Histaminoid reactions associated with rocuronium
J2  - Br J Anaesth
PY  - 2000
VL  - 84
SP  - 108
EP  - 111
ER  - 
TY  - JOUR
LB  - 74.
AU  - Dexter, F
AU  - Gan, TJ
AU  - Naguib, M
AU  - Lubarsky, DA
TI  - Cost identification analysis for succinylcholine
J2  - Anesth Analg
PY  - 2001
VL  - 92
SP  - 693
EP  - 699
ER  - 
TY  - JOUR
LB  - 75.
AU  - Rosenberg, H
AU  - Davis, M
AU  - James, D
AU  - Pollock, N
AU  - Stowell, K
TI  - Malignant hyperthermia
J2  - Orphanet J Rare Dis
PY  - 2007
VL  - 2
SP  - 21
ER  - 
TY  - JOUR
LB  - 76.
AU  - Schreiber, J-U
AU  - Lysakowski, C
AU  - Fuchs-Buder, T
AU  - Tramer, MR
TI  - Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials
J2  - Anesthesiology
PY  - 2005
VL  - 103
SP  - 877
EP  - 884
ER  - 
TY  - JOUR
LB  - 77.
AU  - Cheng, C-R
AU  - Sessler, DI
AU  - Apfel, CC
TI  - Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?
J2  - Anesth Analg
PY  - 2005
VL  - 101
SP  - 1349
EP  - 1355
ER  - 
TY  - JOUR
LB  - 78.
AU  - Tramer, MR
AU  - Fuchs-Buder, T
TI  - Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review
J2  - Br J Anaesth
PY  - 1999
VL  - 82
SP  - 379
EP  - 386
ER  - 
TY  - JOUR
LB  - 79.
AU  - Suresh, D
AU  - Carter, JA
AU  - Whitehead, JP
AU  - Goldhill, DR
AU  - Flynn, PJ
TI  - Cardiovascular changes at antagonism of atracurium. Effects of different doses of premixed neostigmine and glycopyrronium in a ratio of 5: 1
J2  - Anaesthesia
PY  - 1991
VL  - 46
SP  - 877
EP  - 880
ER  - 

LB  - 80.
AU  - Abrishami, A
AU  - Ho, J
AU  - Wong, J
AU  - Chung, F
TI  - Selective reversal of rocuronium-induced neuromuscular block by sugammadex: a systematic review [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 18–22 October 2008
CY  - Orlando, FL
PY  - 2008
SP  - A363
ER  - 
TY  - JOUR
LB  - 81.
AU  - Blobner, M
AU  - Rietbergen, H
AU  - Hermens, Y
AU  - Mirakhur, R
TI  - Recovery from shallow rocuronium-induced neuromuscular blockade is consistently more rapid with sugammadex compared with neostigmine: results from a pooled analysis of phase II and III studies [abstract]
J2  - Eur J Anaesthesiol
PY  - 2008
VL  - 25
SP  - 9AP3–2
ER  - 
TY  - JOUR
LB  - 82.
AU  - Khuenl-Brady, K
AU  - Rietbergen, H
AU  - Prins, M
AU  - Mirakhur, R
TI  - Reversal of shallow vecuronium-induced neuromuscular blockade is achieved more rapidly with sugammadex than with neostigmine: a pooled analysis of phase II and III clinical trials [abstract]
J2  - Eur J Anaesthesiol
PY  - 2008
VL  - 25
SP  - 9AP5
EP  - 9A10
ER  - 
TY  - JOUR
LB  - 83.
AU  - Chiu, JW
AU  - White, PF
TI  - The pharmacoeconomics of neuromuscular blocking drugs
J2  - Anesth Analg
PY  - 2000
VL  - 90
SP  - S19
EP  - S23
ER  - 
TY  - JOUR
LB  - 84.
AU  - Chow, JL
AU  - Macario, A
AU  - Marx, SE
TI  - Cost-effectivenesss of cisatracurium in patients with acute respiratory distress syndrome (ARDS) modeled by Markov computer simulation
J2  - Crit Care Med
PY  - 2003
VL  - 31
SP  - A62
EP  - A62
ER  - 
TY  - JOUR
LB  - 85.
AU  - Loughlin, KA
AU  - Weingarten, CM
AU  - Nagelhout, J
AU  - Stevenson, JG
TI  - A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room
J2  - Pharmacotherapy
PY  - 1996
VL  - 16
SP  - 942
EP  - 950
ER  - 
TY  - JOUR
LB  - 86.
AU  - Macario, A
AU  - Marx, SE
AU  - Chow, JL
TI  - Is cisatracurium cost effective for neuromuscular blockade in the ICU? A Markov computer simulation study
J2  - Value Health
PY  - 2003
VL  - 6
SP  - 373
ER  - 
TY  - JOUR
LB  - 87.
AU  - Ortega, A
AU  - Sarobe, C
AU  - Iribarren, MJ
AU  - Giráldez, J
TI  - Cost analysis of neuromuscular blocking agents in the operating room: cisatracurium, atracurium, vecuronium and rocuronium
J2  - Pharm World Sci
PY  - 2000
VL  - 22
SP  - 82
EP  - 87
ER  - 
TY  - JOUR
LB  - 88.
AU  - White, PF
TI  - Pharmacoeconomic issues related to selection of neuromuscular blocking agents
J2  - Am J Health Syst Pharm
PY  - 1999
VL  - 56
SP  - S18
EP  - S21
ER  - 
TY  - ELEC
LB  - 89.
AU  - Schering-Plough Corporation
TI  - Bridion® (sugammadex). Dose and administration (internet)
M1  - 10 February 2009
UR  - www.bridion.com/HCP/About_Bridion/Dosage_and_Administration/index.asp
ER  - 
TY  - JOUR
LB  - 90.
AU  - Jones, L
AU  - Hawkins, N
AU  - Westwood, M
AU  - Wright, K
AU  - Richardson, G
AU  - Riemsma, R
TI  - Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda®) for locally advanced and/or metastatic breast cancer
J2  - Health Technol Assess
PY  - 2004
VL  - 8
IS  - 5
ER  - 
TY  - BOOK
LB  - 91.
AU  - Curtis, L
TI  - Unit costs of health and social care 2008
CY  - Canterbury
PB  - Personal Social Services Research Unit, University of Kent
PY  - 2008
ER  - 
TY  - GEN
LB  - 92.
AU  - Department of Health
TI  - NHS reference costs 2006–07 (Appendix NSRC1) (internet)
PB  - Department of Health
PY  - 2008
Y2  - 11 February 2009
UR  - www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_082571
ER  - 
TY  - JOUR
LB  - 93.
AU  - Schwartz, DE
AU  - Matthay, MA
AU  - Cohen, NH
TI  - Death and other complications of emergency airway management in critically ill adults. A prospective investigation of 297 tracheal intubations
J2  - Anesthesiology
PY  - 1995
VL  - 82
SP  - 367
EP  - 376
ER  - 
TY  - JOUR
LB  - 94.
AU  - Smith, CE
TI  - Rapid-sequence intubation in adults: indications and concerns
J2  - Clinical Pulmonary Medicine
PY  - 2001
VL  - 8
SP  - 147
EP  - 165
ER  - 
TY  - ELEC
LB  - 95.
AU  - National Statistics
TI  - Mortality statistics
TI  - Deaths registered in 2006. Review of the Registrar General on deaths in England and Wales, 2006
PY  - 2008
UR  - www.statistics.gov.uk/downloads/theme_health/DR-2006/DR_06Mort_Stats.pdf
ER  - 
TY  - BOOK
LB  - 96.
AU  - Kind, P
AU  - Hardman, G
AU  - Macran, S
TI  - UK population norms for EQ-5D
CY  - York
PB  - Centre for Health Economics, University of York
PY  - 1999
ER  - 
TY  - GEN
LB  - 97.
AU  - National Institute for Health and Clinical Excellence (NICE)
TI  - Guide to the methods of technology appraisal
CY  - London
PB  - NICE
PY  - 2008
ER  - 
TY  - JOUR
LB  - 98.
AU  - Abrishami, A
AU  - Ho, J
AU  - Wong, J
AU  - Yin, L
AU  - Chung, F
TI  - Sugammadex, a selective reversal medication for preventing postoperative residual NMB
J2  - Cochrane Database Syst Rev
PY  - 2009
IS  - 4
UR  - 10.1002/14651858.CD007362.pub2
ER  - 

LB  - 99.
AU  - Muendel, K
AU  - Kaminski, E
AU  - Pasternak, R
AU  - Perov, S
TI  - Recovery of 90% TOF after 4mg/kg of sugammadex administration [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 13–17 October 2007
CY  - San Francisco, CA
PY  - 2007
SP  - A843
ER  - 

LB  - 100.
AU  - de Boer, H
AU  - Marcus, M
AU  - Schouten, P
AU  - Heeringa, M
AU  - Driessen, J
TI  - Reversal of rocuronium-induced (1.2 mg/kg) neuromuscular block by Org 25969: a multi center dose finding and safety study [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 21–26 October 2005
CY  - Atlanta, GA
PY  - 2005
SP  - A1117
ER  - 
TY  - JOUR
LB  - 101.
AU  - Flockton, E
AU  - Scanni, E
AU  - Gomar, C
AU  - Shields, M
AU  - Aguilera, L
TI  - Sugammadex after rocuronium provides faster recovery from neuromuscular blockade than neostigmine after cisatracurium [abstract]
J2  - Eur J Anaesthesiol
PY  - 2007
VL  - 24
SP  - 123
ER  - 
TY  - JOUR
LB  - 102.
AU  - Khuenl-Brady, K
AU  - Rex, C
AU  - Sielenkamper, A
AU  - Kjaer, CC
AU  - Eikermann, M
AU  - Larsen, PB
TI  - Reversal of high-dose rocuronium with Org 25969 [abstract]
J2  - Eur J Anaesthesiol
PY  - 2005
VL  - 22
SP  - 121
ER  - 

LB  - 103.
AU  - Rex, C
AU  - Khuenl-Brady, K
AU  - Sielenkaemper, A
AU  - Kjaer, CC
AU  - Puehringer, FK
TI  - Reversal of high-dose rocuronium (1.2 mg/kg) with org 25969 [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 21–26 October 2005
CY  - Atlanta, GA
PY  - 2005
SP  - A1129
ER  - 
TY  - JOUR
LB  - 104.
AU  - Sorgenfrei, I
AU  - Larsen, PB
AU  - Norrild, K
AU  - Stensballe, J
AU  - Østergaard, D
AU  - Prins, ME
TI  - Rapid reversal of rocuronium by the cyclodextrine ORG 25969: a two centre dose finding and safety study [abstract]
J2  - Eur J Anaesthesiol
PY  - 2004
VL  - 21
SP  - 140
ER  - 
TY  - JOUR
LB  - 105.
AU  - Vermeyen, KM
AU  - Sparr, HJ
AU  - Beaufort, AM
AU  - Houwing, NS
AU  - Saldien, V
AU  - Velich-Salchner, C
TI  - Reversal of rocuronium induced neuromuscular block by Org 25969: pharmacokinetics [abstract]
J2  - Eur J Anaesthesiol
PY  - 2004
VL  - 21
SP  - 141
ER  - 

LB  - 106.
AU  - Suy, K
AU  - Morias, K
AU  - Hans, P
AU  - Heeringa, M
AU  - Demeyer, I
TI  - Fast, effective and safe reversal of rocuronium and vecuronium-induced moderate neuromuscular block by the selective relaxant binding agent org 25969 [abstract]
T2  - American Society of Anesthesiologists. Annual meeting
DA  - 21–26 October 2005
CY  - Atlanta, GA
PY  - 2005
SP  - A1119
ER  - 
TY  - GEN
LB  - 107.
AU  - Organon
TI  - A bridging trial comparing Org 25969 at reappearance of T2 in Japanese and Caucasian subjects. Part B: Caucasian subjects (19.4.208B)
CY  - Bethesda, MD
PB  - National Library of Medicine (US)
PY  - 2005–2006
Y2  - 30 May 2008
UR  - http://clinicaltrials.gov/show/NCT00552617 NLM Identifier: NCT00552617
ER  -